4//SEC Filing
Friedland Jeffrey 4
Accession 0001144204-19-023082
CIK 0001625288other
Filed
Apr 30, 8:00 PM ET
Accepted
May 1, 7:56 PM ET
Size
6.9 KB
Accession
0001144204-19-023082
Insider Transaction Report
Form 4
Friedland Jeffrey
DirectorChief Executive Officer10% Owner
Transactions
- Sale
Common Stock
2019-04-04$0.09/sh−5,000,000$425,000→ 19,000,000 total(indirect: By Kanativa USA Inc.)
Holdings
- 833,333
Common Stock
- 228,800(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]The Reporting Person disclaims all beneficial ownership of the securities owned by Kanativa USA Inc., and this report shall not be deemed an admission of beneficial ownership of such securities by the Reporting Person.
- [F2]Kanativa USA Inc. sold 5,000,000 shares effective April 4, 2019.
- [F3]In exchange for the sale of the 5,000,000 shares of common stock, Kanativa USA Inc. received 8,500,000 shares of common stock of Phyto Brands Inc., which valued the shares of Nexien BioPharma Inc. at $0.085 per share.
Documents
Issuer
NEXIEN BIOPHARMA, INC.
CIK 0001625288
Entity typeother
Related Parties
1- filerCIK 0001579962
Filing Metadata
- Form type
- 4
- Filed
- Apr 30, 8:00 PM ET
- Accepted
- May 1, 7:56 PM ET
- Size
- 6.9 KB